InsidersTradesSigma
Follow the PHARMANUTRA PHN - RICAVI PRELIMINARI 2023 stock price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, PHARMANUTRA PHN - RICAVI PRELIMINARI 2023 has recorded 0 public disclosures. Market capitalisation: €794.7m. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA PHN is a company in the health and pharmaceutical sector, listed on the XMIL market. In 2023, it released preliminary results regarding its revenues.